By binding to GLP-1 receptors, Ozempic exerts multiple physiological effects: Enhances glucose-dependent insulin secretion from pancreatic beta cells, improving glycaemic control Suppresses glucagon release , reducing hepatic glucose production Slows gastric emptying , which moderates post-prandial glucose excursions Acts on appetite centres in the brain , particularly the hypothalamus, reducing hunger and promoting satiety These combined actions result in improved blood glucose regulation and, notably, weight loss
It is important to maintain your prescribed regimen and communicate with your doctor about the progress you are observing
These alternative mechanisms may include positive impacts on blood sugar, blood pressure, or inflammation, as well as direct effects on the heart muscle and blood vessels, or a combination of one or more of these. Semaglutide is a GLP-1 medication primarily prescribed for adults with type 2 diabetes but is also approved for weight loss in people with obesity or overweight who have at least one other health issue
Since these products cause nausea or vomiting, they can lead patients or clinicians to reduce or stop insulin due to missed meals
Use our peptide calculator to determine exact injection volumes based on your specific formulation concentration